Jacob Gottlieb, MD, PRMIA, CFA, is an entrepreneur in the financial industry. He entered this industry in 2001 after earning his medical degree. With his background as a trained medical doctor, he invests strictly in healthcare firms. He started out at Sanford C. Bernstein & Co., LLC, and worked there for two years as an analyst who would help determine what healthcare companies to invest in.
He first became a portfolio manager at Merlin and then Jacob Gottlieb went on to co-found Balyasny Asset Management, L.P. (BAM). It was at BAM that he established his reputation as a savvy hedge fund manager as his fund made large gains. He then founded Visium Asset Management, LLC. This was a highly successful hedge fund but, unfortunately, a number of his executives turned out to be engaged doing insider trading. The government authorities cleared his name but, nevertheless, he had to wind down operations and close up shop.
His new hedge fund firm is called Altium Capital and it is based in New York City. Jacob Gottlieb continues to do what he does best which is invest in cutting-edge healthcare firms that are creating exciting treatments for diseases. The first company he chose to invest in was Oramed Pharmaceutical in which he took a 5.61 percent stake. They are developing oral treatments for diabetes which has been a long sought-out goal in the healthcare field. They now have three products on the market and a lot of exciting things under development.
Jacob Gottlieb also invested in Amarin which as an office in Bedminster, NJ, and is based in Dublin, Ireland. They are developing treatments for cardiovascular disease and have one product, Vascepa, that has been FDA-approved. He also invested in Oragenics which does Replacement Therapy, developing treatments that replace negative bacteria with positive ones.
The founder of Carrollton, Texas-based MB2 Dental Solutions, Dr. Chris Steven Villanueva, says that he wanted to shake up the dental office support industry when he created this firm. He says that it has always been a very formal and staid industry with about as much life as a doorknob. He introduced a company where the management and employees can actually have a personality and enjoy their day while helping dentist’s treat patients. This has proven to be a winning concept and his company now has affiliated locations in six states and counting.
Dr. Chris Villanueva was pleased to recently introduce MB2 Dental Solution’s new Chief Financial Officer Jackson Hildebrand. This company needed to bring someone in who could handle the growth this company has seen over the past several years. Dr. Chris Villanueva, who is also the chief executive officer, said that MB2 Dental Solutions offers a unique platform. The dentists and this company partner together where they invest in each other both financially and professionally. They needed to hire someone for the CFO position who was both great at finance as well as understanding the particular challenges that dental practices have.
Jackson Hildebrand had been working for a private equity firm for the past several years. He had been looking to transition over to working directly for a portfolio company like MB2 Dental Solutions because he would then be involved in the day-to-day happenings. He says he was also drawn to the culture of this company which is one that is fun and tight-knit. MB2 Dental Solutions and a group of 16 of their affiliated dentists traveled to Jamaica in the fall of 2017. The reason for this trip was to provide dental services to the people who live in a number of remote villages. Most of these people had never been to a dentist in their lives and as a result had all sorts of issues with their teeth. In addition to doing dental work for free on both children and adults they provided education in order to help prevent future issues. Altogether they treated over 400 people during this trip.
Ms. Penelope Kokkinides was the operating officer at the Innovacare health solutions from 2006 to 2012. She also served in Aveta Inc as the chief operating officer. From 2008 she served at Touchstones as the chief operating officer. For over two decades now she has the experience of managing healthcare and has specialized in government programs. Before joining Aveta, she served as the corporate vice president for care and management and disease management at the Americhoice which is a business unit of united health group, here she was vital in the development and implementation of the healthcare model.
Penelope Kokkinides graduated from the Binghamton University with the B.S in biological sciences and classical languages, and she later joined New York University for her first masters in social work, she finally did her second masters at Columbia University where she specialized with public health. She did language fluency in Greek.
Invited in Whitehouse Penelope Kokkinides was among seven other women invited to a panel by united states president Donald Trump to sit at a roundtable to discuss about health affairs. During the meeting she mentioned the importance of fund increment for Medicare as from the year 2011 there was federal funding cut in Puerto Rico for Medicare which dropped the advantage by an annual amount of about $1 billion an amount that is significantly inappropriate to the reductions in the united states.
Penelope Kokkinides recommended that fixing of the cuts be done since it’s not only an important thing to do, but it is a responsible thing because when the Medicaid system collapses in Puerto Rico there will be many people who will be forced to migrate from the island headed for the states where their Medicaid cost may have gone higher three to four times. Days after meeting president Trump released a notice, and that final notice provided favorable changes for the Puerto Rico healthcare systems.
Innovacare, Inc gives health services in Puerto Rico and manages other two government Medicaid plans within the area which brings broad benefit coverage through a structured care model. Invacare also is dedicated to offering the island with accredited health plans and world-class healthcare services through creating sustainable models of monitored care, cost friendly, innovative and integrated technology. To sum all this Ms. Penelope Kokkinides presence in the healthcare systems for over 20 years has brought massive changes that have benefited both Puerto Ricans and the United States.
Jim Tananbaum serves as the Chief Executive Officer and Founder of Foresite Capital. In 2011, Jim Tananbaum Foresite Capital founded Foresite Capital, a private equity healthcare firm that specializes in the identification of emerging leaders in the healthcare industry.
About Foresite Capital
The headquarters of Foresite Capital are in San Francisco. Furthermore, in New York, the Healthcare firm also has an additional office. Foresite Capital invests in the top most innovative healthcare companies. Also, the company offers growth capital to emerging healthcare providers in the private and public sectors. The investments are done on enterprises that have disruptive last-stage services as products. The company is valued at about 1.1 billion dollars in terms of assets. Intarcia is Foresite’s latest and largest investment. Intarcia is a type II diabetes implant that helps patients to control their diabetes and weight.
About Jim Tananbaum
Before establishing Foresite Capital, Jim was a co-founder of two healthcare investment practices and two biopharmaceutical companies. Jim Tananbaum has over 25years of experience in the healthcare sector where he has served at management positions at GelTex and Theravance Pharmaceuticals. In 1998, GelTex was acquired for 1.6 billion dollars, and its lead drug called Renzela had an excess revenue rate of 200 million dollars. He is also a founding partner at Sierra Ventures and Prospect Venture Partners II and III. Check out his About.me page
In 1998, Jim Tananbaum obtained an M. D and an M.B.A from Havard Business School. Jim also majored in Math and computer science/electrical engineering from Yale University. Jim holds an M.S. from the Massachusetts Institute of Technology. He has productive and long-term relationships with leading academicians and has been mentored by Rick Levin from Yale, George Whitesides from Harvard and Roy Vagelos from Theravance. Jim continues to collaborate with these leading academicians and entrepreneurs in a bid to develop new great insights in the healthcare industry.
Jim Tananbaum has appeared on the Midas List for three years straight. This list features the top hundred investors. Jim has undertaken various major investments in the health sector including two diabetes treatment unicorns known as Juno Therapeutics and Intarcia Therapeutics.
See more: https://ideamensch.com/jim-tananbaum/